Bison Ventures Review: Backing Frontier Technology for a Healthier World

Bison Ventures is a Seattle and San Francisco-based early-stage venture firm that closed a $135 million fund in 2024, making it one of the better-capitalized debut funds in the frontier tech space. The firm was founded in 2021 by Tom Biegala and Ben Hemani, who previously worked together at other venture firms before launching Bison to focus on what they call "frontier technology"—companies using deep science and innovative engineering to address large global challenges in health and sustainability.

The firm operates with a lead-and-co-lead investment philosophy, typically investing $250,000 to $10 million per deal with a sweet spot around $5 million. Bison has gained recognition for making early, conviction-based bets on companies before they become obvious to the broader market. Their portfolio already includes several companies that have gone on to raise significant follow-on rounds from top-tier investors.

Bison Ventures differentiates itself through hands-on engagement with founders. Partners Caleb Appleton, Tom Biegala, and Ben Hemani each bring technical backgrounds and operational experience that they deploy to help portfolio companies navigate the unique challenges of deep tech development, regulatory pathways, and scaling hardware or scientific products.

The firm has been particularly active in the past two years, deploying capital across AI in the physical world, techbio, climate and sustainability technologies, and what Bison calls "10x hardware"—physical products that represent order-of-magnitude improvements over existing solutions. This breadth reflects the partners' belief that the most impactful companies will emerge at the intersection of multiple technological disciplines.

Founders seeking to understand Bison Ventures should recognize that the firm is genuinely founder-friendly and takes a long-term view of its partnerships. The firm's website at https://www.bison.vc/ provides background on the partners' perspectives and investment approach, though the best way to get on Bison's radar remains warm introductions from their existing portfolio founders or other investors the partners trust.

Bison Ventures invests exclusively in frontier technology companies—startups that leverage genuine scientific innovation or deeply technical engineering rather than software-only business model improvements. The firm's thesis centers on the conviction that solving the world's most pressing challenges in health and environment will require companies with hard IP, novel science, and differentiated technology moats.

The four investment verticals reflect where the partners see the most opportunity for transformative companies. "AI in the Physical World" captures robotics, autonomous systems, and AI applications that interact with the physical environment rather than operating purely in software. "Techbio" encompasses therapeutic development, synthetic biology, and health technology companies that apply computational approaches to biological challenges.

"Climate and sustainability" investments focus on companies addressing environmental challenges through novel materials, processes, or technologies that reduce environmental impact or enable more sustainable economic activity. "10x Hardware" captures physical products that represent order-of-magnitude improvements—such as dramatically lower cost, dramatically better performance, or entirely new capability categories.

Bison evaluates opportunities across all four verticals using consistent criteria: team depth and technical credibility, size and growth trajectory of the target market, defensibility of the technology through IP or proprietary data, and the potential for meaningful impact on the challenge being addressed. The firm has demonstrated willingness to invest in highly technical domains where domain expertise is required to properly evaluate the opportunity.

A distinctive aspect of Bison's thesis is their openness to hardware-intensive businesses, which many venture firms avoid due to capital intensity and longer development timelines. The partners have signaled comfort with hardware bets, viewing them as offering more durable competitive advantages than pure software businesses. This positions Bison differently from generalist early-stage funds that tend to prefer software scalability.

Bison Ventures has maintained an active investment pace through 2024 and into 2026, participating in multiple significant rounds across its focus verticals. The firm's ability to lead larger rounds has grown as its $135M fund provides more flexibility to write meaningful checks at Series A and to follow on in existing portfolio companies.

The firm demonstrated its willingness to lead growth-stage rounds in early 2026 when it co-led a $20 million Series A round in Grid Aero, an aerospace startup building autonomous aircraft for long-range cargo operations. Bison co-led the round with Geodesic Capital, marking one of the firm's largest investments to date and demonstrating appetite for hardware-intensive aerospace companies with clear commercial applications.

Bison also led Juvena Therapeutics' $33.5 million Series B round in January 2026, with participation from Eli Lilly, Jefferson Life Sciences, and Mubadala Capital. The investment in Juvena—a clinical-stage biotech developing AI-enabled regenerative biologics—reflects the firm's thesis around techbio and represents a significant signal about Bison's willingness to back later-stage therapeutic development.

Earlier-stage activity includes leading a $14 million seed round in Great Sky, a startup developing superconducting optoelectronic technology for AI computing applications. The round was notable for being one of Bison's largest seed investments and for targeting a technically ambitious hardware problem at the intersection of computing infrastructure and AI demand.

The firm's portfolio of approximately 17 companies shows the breadth of its investment activity, spanning early pre-seed bets through Series B growth investments. Bison has demonstrated willingness to back companies across stages when conviction is high, though the majority of the portfolio remains weighted toward seed and Series A where the firm's initial investments were made.

Bison Ventures' portfolio showcases the firm's commitment to backing deeply technical companies with potential for outsized impact. The portfolio includes companies across aerospace, biotechnology, computing infrastructure, robotics, and sustainability—reflecting the breadth of the firm's investment thesis.

Juvena Therapeutics stands as one of the portfolio's most advanced companies. The clinical-stage biotech uses AI to develop regenerative biologics pipelines, targeting conditions including sarcopenia and diabetic kidney disease. Bison's leadership of the company's $33.5M Series B in early 2026, alongside major corporate investors like Eli Lilly, signals strong conviction in Juvena's approach and platform potential.

Grid Aero is building autonomous aircraft for long-range cargo operations, an application of AI and robotics that addresses real commercial logistics needs. The company emerged from stealth in 2024 with a $6M seed round and followed with a $20M Series A in early 2026, co-led by Bison and Geodesic Capital. The investment reflects Bison's interest in aerospace applications of autonomous systems.

Allonnia, which raised more than $20M in a Series A extension in late 2025 bringing total funding to over $100M, is developing critical materials biotechnology with commercial applications in mining and resource extraction. The company counts Viking Global Investors, General Atlantic, BHP Ventures, and Pivotal Capital Partners as co-investors alongside Bison—demonstrating the quality of investor syndicate that Bison helps assemble.

Great Sky's $14M seed round, led by Bison in early 2026, targets the intersection of AI computing demand and novel hardware solutions. The company's superconducting optoelectronic technology for AI computing represents a technically ambitious bet on next-generation computing infrastructure. Other portfolio companies include Bonsai Robotics, Cobot, Cosmon, Frontera Health, Innerplant, Passkey, Semaphor, Sleuth, Thinking Machines, Vivodyne, and Zyphra, covering applications from robotics to enterprise AI.

Bison Ventures evaluates potential investments primarily on team depth and technical credibility. The firm looks for founding teams with direct expertise in the technical domain they are operating in—not just business operators who have learned enough to pitch a technical idea. This is particularly true in Bison's techbio and hardware verticals where technical due diligence is more intensive.

The market opportunity must be large and growing, with a clear pathway to meaningful revenue in a reasonable timeframe. Bison has less patience for companies with long development timelines without intermediate milestones, so founders should be prepared to articulate both the technical roadmap and the commercial strategy with equal clarity.

Defensibility through intellectual property or proprietary data assets is a key evaluation criterion. Bison prefers companies where the competitive moat is structural—protected by patents, trade secrets, unique datasets, or extreme technical differentiation—rather than companies that rely primarily on speed to market or customer relationships for advantage.

The environmental and health impact dimension matters to Bison's partners. The firm is explicit about wanting to back companies that address global challenges in these domains, and founders should frame their value proposition with this impact angle in mind. This is not just marketing language—it reflects the partners' actual investment thesis and the criteria they use to evaluate opportunities.

Bison looks for companies where their capital and engagement can be genuinely catalytic. The firm prefers being the lead or co-lead investor and wants to be involved early enough to help shape company direction, strategy, and team building. Founders who are looking for passive capital or who are already too far along for meaningful partnership may find less alignment with Bison's approach.

The most effective path to Bison Ventures is through warm introductions from founders in their existing portfolio, other investors the partners trust, or advisors who have relationships with the firm. Bison partners actively seek deal flow through their network, and a credible introduction from a trusted source significantly increases the likelihood of a meeting.

Founders without direct connections should focus on building relationships before formally pitching. Following Bison's partners on social media, attending industry events where they speak, and engaging with content they publish can create natural touchpoints. Bison partners are relatively accessible compared to some other firms, and founders who demonstrate genuine understanding of the firm's thesis will stand out.

Cold outreach through the firm's website is possible but less effective. If pursuing this path, founders should ensure their pitch deck clearly articulates why their company fits Bison's specific investment thesis in one of the four verticals, provides evidence of technical differentiation, and demonstrates understanding of the problem being solved. Generic pitch decks that could apply to any VC will not generate responses.

When preparing for a meeting with Bison, founders should be ready to discuss technical depth in their domain, not just business metrics. The partners will probe technical claims and want to understand the scientific or engineering basis for the company's approach. Business model, commercial strategy, and team background remain important, but founders should not be surprised when Bison partners focus significant time on technical due diligence.

Follow-up after initial meetings is important. Bison's deal process typically runs 2-4 weeks from initial meeting to decision, and founders should maintain appropriate communication without being overly pushy. Sending updates on milestones and progress is welcomed and helps keep the relationship active if Bison passes initially but wants to revisit in a future round.

While Bison Ventures invests in deep tech and frontier technology companies, they expect founders to have a solid command of their business's financial mechanics. Investors need to see that the team understands burn rate, runway, SaaS unit economics, and the path to either profitability or the next financing milestone. This is especially important for companies with longer development timelines.

First-time founders in deep tech sometimes underestimate the importance of financial preparedness, assuming that technical differentiation is sufficient to raise capital. Bison partners have seen enough companies fail at the intersection of technical ambition and financial mismanagement to require founders to demonstrate financial fluency as part of the evaluation.

Working with a fractional CFO can significantly improve your positioning when pitching Bison Ventures and comparable investors. Professional financial guidance helps founders build accurate projections that reflect realistic technical timelines and commercial milestones, prepare investor-ready financials, and confidently navigate due diligence conversations.

Our team has helped numerous frontier technology companies raise capital and would be happy to discuss how we can support your fundraising efforts. From pitch deck financials to comprehensive financial models that reflect the realities of deep tech development timelines, we ensure founders are prepared for the investment process.

Financial projections should be grounded in evidence and reflect realistic assumptions about customer acquisition, pricing, and timeline to revenue. Bison's partners will challenge optimistic projections and expect founders to have considered multiple scenarios, including downside cases where milestones take longer or capital efficiency is lower than hoped.

Understanding your key performance indicators and being able to explain trends in your metrics is essential when pitching to Bison or comparable investors. The firm wants to see that founders track what matters, can identify when performance deviates from plan, and have strategies for correcting course when necessary.

Whether you're preparing to pitch Bison Ventures or other frontier technology investors, having professional financials and a clear understanding of your metrics can set you apart from competitors. Our team has helped companies at various stages build investor-ready materials that clearly communicate their business model, growth trajectory, and path to returns.

Exploring other venture capital firms with similar investment theses? Our comprehensive collection of VC firm reviews covers investors across all stages and sectors, including funds focused on frontier technology, climate, and deep tech.

Each review provides detailed information about investment criteria, portfolio companies, and strategies for securing funding. Whether you're looking for seed-stage investors focused on climate technology or growth equity firms backing deep tech platforms, you'll find relevant insights in our VC firm guides.

Finding the right investor for your startup is crucial to your success and can significantly impact your company's trajectory. Take the time to research potential investors and understand their investment thesis, portfolio composition, and team backgrounds before reaching out.

Our guides cover major venture capital firms as well as emerging managers that may offer more focused engagement and better fit for your company's specific needs and stage of development.